Treatment-Refractory Nodular Scleritis.
Francis JH, Gobin YP, Diamond EL.
JAMA Ophthalmol. 2022 Sep 15. doi: 10.1001/jamaophthalmol.2022.3591. Online ahead of print.
Management of noninfectious scleritis.
Abdel-Aty A, Gupta A, Del Priore L, Kombo N.
Ther Adv Ophthalmol. 2022 Jan 21;14:25158414211070879. doi: 10.1177/25158414211070879. eCollection 2022 Jan-Dec.
[Treatment-resistant nodular scleritis].
Hübner L, Mardin CY, Held J, Tappe D, Hammer CM, Bergua A.
Ophthalmologie. 2023 Jan;120(1):72-75. doi: 10.1007/s00347-022-01597-4. Epub 2022 Mar 8.
[Diagnosis and treatment of episcleritis and scleritis].
Tappeiner C, Walscheid K, Heiligenhaus A.
Ophthalmologe. 2016 Sep;113(9):797-810. doi: 10.1007/s00347-016-0344-3.
Pembrolizumab-Induced Nodular Posterior Scleritis.
McNelly CL, Haider AA, Wann RC, Crosson JN, Mason JO 3rd.
J Vitreoretin Dis. 2023 Apr 10;7(4):348-351. doi: 10.1177/24741264231163396. eCollection 2023 Jul-Aug.
Scleritis.
Lagina A, Ramphul K.
2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Nodular scleritis-a rare presentation of COVID-19& variation with testing.
Adenwala A, Shetty R, D'Souza S, Mahendradas P, Kundu G.
Am J Ophthalmol Case Rep. 2022 Mar;25:101396. doi: 10.1016/j.ajoc.2022.101396. Epub 2022 Feb 3.
Multimodal Imaging of Nodular Posterior Scleritis: Case Report and Review of the Literature.
Alsarhani WK, Abu El-Asrar AM.
Middle East Afr J Ophthalmol. 2020 Jul 20;27(2):134-138. doi: 10.4103/meajo.MEAJO_115_20. eCollection 2020 Apr-Jun.
Scleritis therapy.
Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS.
Ophthalmology. 2012 Jan;119(1):51-8. doi: 10.1016/j.ophtha.2011.07.043. Epub 2011 Oct 19.
Syphilitic Scleritis.
Fénolland JR, Bonnel S, Rambaud C, Froussart-Maille F, Rigal-Sastourné JC.
Ocul Immunol Inflamm. 2016;24(1):93-5. doi: 10.3109/09273948.2014.916307. Epub 2014 May 15.
